On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
58° Feels Like: 58°
Wind: W 8 mph Past 24 hrs - Precip: 0.12”
Current Radar for Zip

Tonight

Partly Cloudy 32°

Tomorrow

Sunny 66°

Mon Night

Showers Late 38°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Gilead says on track with hepatitis C treatments

(Reuters) - Gilead Sciences Inc is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus (HCV) infection, starting in mid-2013, the biotech company said on Monday.

Gilead is scheduled to give investors an update on its candidates for HCV treatment at a JPMorgan healthcare conference this week in San Francisco.

The company will discuss new results from an arm of a continuing Phase 2 trial and provide a progress report on a range of Phase 2 and 3 trials evaluating a once-daily fixed-dose combination tablet of the medicines.

(Reporting by Debra Sherman; editing by John Wallace)

Comments